Stockreport

Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound [CNBC]

Eli Lilly and Company  (LLY) 
Last eli lilly and company earnings: 4/23 06:25 am Check Earnings Report
US:NYSE Investor Relations: investor.lilly.com
PDF The company also said it has filed for Food and Drug Administration approval of the daily GLP-1 pill, called orforglipron, for obesity. The positive trial data sugges [Read more]